OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. CRWV
8. MSFT
9. MH
10. DLMAF

Go back to OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer
VERACYTE (NASDAQ: VCYT) Delayed: 47.12 -0.3 (0.63%)
Previous Close $47.42    52 Week High $8.45 
Open $47.51    52 Week Low $4.21 
Day High $48.63    P/E N/A 
Day Low $46.53    EPS $-1.52 
Volume 172,394